Chronic Myeloid Leukemia (CML-BP) Terminated Phase 1 Trials for Masoprocol (DB00179)

IndicationStatusPhase
DBCOND0040419 (Chronic Myeloid Leukemia (CML-BP))Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00664677Phase 1 Study of Terameprocol (EM-1421) in Patients With LeukemiaTreatment